Show simple item record

dc.contributor.authorRiemann, Dieter
dc.contributor.authorEspie, Colin A.
dc.contributor.authorAltena, Ellemarije
dc.contributor.authorArnardottir, Erna Sif
dc.contributor.authorBaglioni, Chiara
dc.contributor.authorBassetti, Claudio L. A.
dc.contributor.authorBastien, Celyne
dc.contributor.authorBerzina, Natalija
dc.contributor.authorBjorvatn, Bjørn
dc.contributor.authorDikeos, Dimitris
dc.contributor.authorDolenc Groselj, Leja
dc.contributor.authorEllis, Jason G.
dc.contributor.authorGarcia-Borreguero, Diego
dc.contributor.authorGeoffroy, Pierre A.
dc.contributor.authorGjerstad, Michaela-Alexandra Dreetz
dc.contributor.authorGonçalves, Marta
dc.contributor.authorHertenstein, Elisabeth
dc.contributor.authorHoedlmoser, Kerstin
dc.contributor.authorHion, Tuuliki
dc.contributor.authorHolzinger, Brigitte
dc.contributor.authorJanku, Karolina
dc.contributor.authorJansson-Fröjmark, Markus
dc.contributor.authorJärnefelt, Heli
dc.contributor.authorJernelöv, Susanna
dc.contributor.authorJennum, Poul Jørgen
dc.contributor.authorKhachatryan, Samson
dc.contributor.authorKrone, Lukas
dc.contributor.authorKyle, Simon D.
dc.contributor.authorLancee, Jaap
dc.contributor.authorLeger, Damien
dc.contributor.authorLupusor, Adrian
dc.contributor.authorMarques, Daniel Ruivo
dc.contributor.authorNissen, Christoph
dc.contributor.authorPalagini, Laura
dc.contributor.authorPaunio, Tiina
dc.contributor.authorPerogamvros, Lampros
dc.contributor.authorPevernagie, Dirk
dc.contributor.authorSchabus, Manuel
dc.contributor.authorShochat, Tamar
dc.contributor.authorSzentkiralyi, Andras
dc.contributor.authorVan Someren, Eus
dc.contributor.authorvan Straten, Annemieke
dc.contributor.authorWichniak, Adam
dc.contributor.authorVerbraecken, Johan
dc.contributor.authorSpiegelhalder, Kai
dc.description.abstractProgress in the field of insomnia since 2017 necessitated this update of the European Insomnia Guideline. Recommendations for the diagnostic procedure for insomnia and its comorbidities are: clinical interview (encompassing sleep and medical history); the use of sleep questionnaires and diaries (and physical examination and additional measures where indicated) (A). Actigraphy is not recommended for the routine evaluation of insomnia (C), but may be useful for differential-diagnostic purposes (A). Polysomnography should be used to evaluate other sleep disorders if suspected (i.e. periodic limb movement disorder, sleep-related breathing disorders, etc.), treatment-resistant insomnia (A) and for other indications (B). Cognitive-behavioural therapy for insomnia is recommended as the first-line treatment for chronic insomnia in adults of any age (including patients with comorbidities), either applied in-person or digitally (A). When cognitive-behavioural therapy for insomnia is not sufficiently effective, a pharmacological intervention can be offered (A). Benzodiazepines (A), benzodiazepine receptor agonists (A), daridorexant (A) and low-dose sedating antidepressants (B) can be used for the short-term treatment of insomnia (≤ 4 weeks). Longer-term treatment with these substances may be initiated in some cases, considering advantages and disadvantages (B). Orexin receptor antagonists can be used for periods of up to 3 months or longer in some cases (A). Prolonged-release melatonin can be used for up to 3 months in patients ≥ 55 years (B). Antihistaminergic drugs, antipsychotics, fast-release melatonin, ramelteon and phytotherapeutics are not recommended for insomnia treatment (A). Light therapy and exercise interventions may be useful as adjunct therapies to cognitive-behavioural therapy for insomnia (B).en_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.titleThe European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023en_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.rights.holderCopyright 2023 The Author(s)en_US
dc.source.journalJournal of Sleep Researchen_US
dc.identifier.citationJournal of Sleep Research. 2023, 32 (6), e14035.en_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal